BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21518339)

  • 1. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
    Fattore L; Spano M; Melis V; Fadda P; Fratta W
    Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
    Spano MS; Fattore L; Cossu G; Deiana S; Fadda P; Fratta W
    Br J Pharmacol; 2004 Oct; 143(3):343-50. PubMed ID: 15339858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
    Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
    Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats.
    De Vries TJ; Homberg JR; Binnekade R; Raasø H; Schoffelmeer ANM
    Psychopharmacology (Berl); 2003 Jul; 168(1-2):164-169. PubMed ID: 12669182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
    Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L
    Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.
    Braida D; Pozzi M; Parolaro D; Sala M
    Eur J Pharmacol; 2001 Feb; 413(2-3):227-34. PubMed ID: 11226397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional cannabinoid modulation of social behavior in adolescent rats.
    Trezza V; Vanderschuren LJ
    Psychopharmacology (Berl); 2008 Apr; 197(2):217-27. PubMed ID: 18058088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the cannabinoid CB1 receptor in the opioid inhibition of the response to cholecystokinin and acute withdrawal response.
    Romanelli L; Palmery M; Tucci P; Amico MC; Morrone LA; Valeri P
    Neurotoxicology; 2005 Oct; 26(5):819-27. PubMed ID: 15913779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
    Braida D; Pozzi M; Cavallini R; Sala M
    Neuroscience; 2001; 104(4):923-6. PubMed ID: 11457579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
    Alvarez-Jaimes L; Polis I; Parsons LH
    Neuropsychopharmacology; 2008 Sep; 33(10):2483-93. PubMed ID: 18059440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
    Tanda G; Pontieri FE; Di Chiara G
    Science; 1997 Jun; 276(5321):2048-50. PubMed ID: 9197269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
    Ward SJ; Rosenberg M; Dykstra LA; Walker EA
    Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.
    Fattore L; Spano MS; Altea S; Fadda P; Fratta W
    Br J Pharmacol; 2010 Jun; 160(3):724-35. PubMed ID: 20590575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.
    Manzanedo C; Rodríguez-Arias M; Daza-Losada M; Maldonado C; Aguilar MA; Miñarro J
    Behav Brain Funct; 2010 Mar; 6():19. PubMed ID: 20307280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats.
    Fattore L; Spano MS; Cossu G; Deiana S; Fratta W
    Eur J Neurosci; 2003 Apr; 17(8):1723-6. PubMed ID: 12752390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity.
    Lever IJ; Pheby TM; Rice AS
    Br J Pharmacol; 2007 May; 151(2):292-302. PubMed ID: 17375083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.